RecruitingNCT05324553

Patient Derived Preclinical Models

Sponsor

Mayo Clinic

Enrollment

50 participants

Start Date

Apr 6, 2022

Study Type

OBSERVATIONAL

Conditions

Cancer

Summary

Study goal is to collect tumor specimens that may inform cancer biology to eventually improve outcomes for patients with cancer. This proposal represents a highly collaborative effort to support cancer research with the goal of developing novel therapeutic strategies using patient derived preclinical models. This study is being done to collect samples of tumor tissues, matched normal tissue when possible, and approximately 50 mL of blood.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood Collection, Buccal Swab, and others for people with cancer. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETissue Collection

Research tissue specimen will be obtained during the patient's clinical biopsy or clinical tumor resection, if feasible.

DIAGNOSTIC_TESTBlood Collection

Up to 50 mL of research blood will be drawn around the time of the procedure. Additional blood may be collected in selected cases, as warranted, to monitor disease recurrence/remission or perform additional

DIAGNOSTIC_TESTBuccal Swab

Buccal swab may be requested, if necessary, to generate germline data.